LifeMD® Now Offering Eli Lilly and Company's Foundayo(TM) (orforglipron), a New GLP-1 Pill for Weight Management

Stock Information for LifeMD Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About LifeMD Inc.

LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team
LifeMD Reports Fourth Quarter and Full Year 2025 Results
LifeMD to Participate in Two Investor Conferences During March
LifeMD to Report Fourth Quarter 2025 Financial Results on March 9
Johnson Fistel, PLLP Begins Investigation on Behalf of Long-Term Shareholders of Jasper Therapeutics, Inc. (JSPR), KBR, Inc. (KBR), LifeMD, Inc. (LFMD), and Lineage, Inc. (LINE)
Kuehn Law Encourages Investors of LifeMD, Inc. to Contact Law Firm

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.